82 FR 21826 - National Library of Medicine Amended; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 89 (May 10, 2017)

Page Range		21826-21827
FR Document		2017-09414

Federal Register, Volume 82 Issue 89 (Wednesday, May 10, 2017)

[Federal Register Volume 82, Number 89 (Wednesday, May 10, 2017)]
[Notices]
[Pages 21826-21827]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09414]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Library of Medicine Amended; Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Library of Medicine Biomedical Library and Informatics Review 
Committee, June 15, 2017, 9:00 a.m. to 6:00 p.m., and June 16, 2017, 
9:00 a.m. to 2:00 p.m., National Library of Medicine, Building 38, 
Lindberg Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD, 20892 
which was published in the Federal Register on February 27, 2017, 82 FR 
37, Page 11934.

[[Page 21827]]

    The second day of the Biomedical Library and Informatics Review 
Committee meeting, June 16, 2017, will now be held from 8:00 a.m. to 
6:00 p.m. instead of 8:00 a.m. to 2:00 p.m. The meeting is closed to 
the public.

    Dated: May 4, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-09414 Filed 5-9-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 89 / Wednesday, May 10, 2017 / Notices 21827

The second day of the Biomedical Branch, Division of Extramural Activities, 708–2301. Copies of non-confidential
Library and Informatics Review National Cancer Institute, NIH, 9609 Medical documents filed in connection with this
Committee meeting, June 16, 2017, will Center Drive, Room 7W236, Bethesda, MD investigation are or will be available for
20892–9750, 240–276–5120, coynes@
now be held from 8:00 a.m. to 6:00 p.m. inspection during official business
mail.nih.gov.
instead of 8:00 a.m. to 2:00 p.m. The hours (8:45 a.m. to 5:15 p.m.) in the
Name of Committee: National Cancer
meeting is closed to the public. Office of the Secretary, U.S.
Institute Special Emphasis Panel;
Dated: May 4, 2017. Partnerships in Cancer Research (P20) and International Trade Commission, 500 E
Michelle Trout, Cancer Health Equity (U54). Street SW., Washington, DC 20436,
Program Analyst, Office of Federal Advisory Date: June 20–21, 2017. telephone (202) 205–2000. General
Committee Policy. Time: 7:30 a.m. to 2:00 p.m. information concerning the Commission
[FR Doc. 2017–09414 Filed 5–9–17; 8:45 am]
Agenda: To review and evaluate grant may also be obtained by accessing its
applications. Internet server at https://www.usitc.gov.
BILLING CODE 4140–01–P Place: Bethesda North Marriott Hotel & The public record for this investigation
Conference Center, 5701 Marinelli Road, may be viewed on the Commission’s
Bethesda, MD 20852.
DEPARTMENT OF HEALTH AND electronic docket (EDIS) at https://
Contact Person: Clifford Schweinfest,
HUMAN SERVICES Ph.D., Scientific Review Officer, Special edis.usitc.gov. Hearing-impaired
Review Branch, Division of Extramural persons are advised that information on
National Institutes of Health Activities, National Cancer Institute, NIH, this matter can be obtained by
9609 Medical Center Drive, Room 7W108, contacting the Commission’s TDD
National Cancer Institute; Notice of Bethesda, MD 20892–9750, 240–276–6343, terminal on (202) 205–1810.
Closed Meetings schweinfestcw@mail.nih.gov. SUPPLEMENTARY INFORMATION: The
Pursuant to section 10(d) of the (Catalogue of Federal Domestic Assistance Commission instituted this investigation
Federal Advisory Committee Act, as Program Nos. 93.392, Cancer Construction; on January 27, 2015, based on a
93.393, Cancer Cause and Prevention Complaint filed by Cisco Systems, Inc.
amended (5 U.S.C. App.), notice is
Research; 93.394, Cancer Detection and of San Jose, California (‘‘Cisco’’). 80 FR
hereby given of the following meetings. Diagnosis Research; 93.395, Cancer
The meetings will be closed to the 4313–14 (Jan. 27, 2015). The Complaint
Treatment Research; 93.396, Cancer Biology
public in accordance with the Research; 93.397, Cancer Centers Support; alleges violations of section 337 of the
provisions set forth in sections 93.398, Cancer Research Manpower; 93.399, Tariff Act of 1930, as amended, 19
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Cancer Control, National Institutes of Health, U.S.C. 1337, in the sale for importation,
as amended. The grant applications and HHS) importation, and sale within the United
the discussions could disclose Dated: May 4, 2017. States after importation of certain
confidential trade secrets or commercial network devices, related software and
Melanie J. Pantoja,
property such as patentable material, components thereof by reason of
Program Analyst, Office of Federal Advisory
and personal information concerning infringement of certain claims of U.S.
Committee Policy.
individuals associated with the grant Patent Nos. 7,023,853; 6,377,577;
[FR Doc. 2017–09412 Filed 5–9–17; 8:45 am]
applications, the disclosure of which 7,460,492; 7,061,875; 7,224,668; and
BILLING CODE 4140–01–P 8,051,211. The Complaint further
would constitute a clearly unwarranted
invasion of personal privacy. alleges the existence of a domestic
Name of Committee: National Cancer
industry. The Commission’s Notice of
Institute Special Emphasis Panel; INTERNATIONAL TRADE Investigation named Arista Networks,
Coordinating Center for Population-based COMMISSION Inc. of Santa Clara, California (‘‘Arista’’)
Research to Optimize the Screening Process. as respondent. The Office of Unfair
[Investigation No. 337–TA–945]
Date: June 13, 2017. Import Investigations (‘‘OUII’’) was also
Time: 10:00 a.m. to 5:00 p.m. named as a party to the investigation.
Agenda: To review and evaluate grant
Certain Network Devices, Related
Software and Components Thereof (II); The Commission previously terminated
applications.
Commission Final Determination of the investigation in part as to certain
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room Violation of Section 337; Termination claims of the asserted patents. Order No.
7W112, Rockville, MD 20850 (Telephone of Investigation; Issuance of Limited 38 (Oct. 27, 2015), unreviewed Notice
Conference Call). Exclusion Order and Cease and Desist (Nov. 18, 2015); Order No. 47 (Nov. 9,
Contact Person: Jennifer C. Schiltz, Ph.D., Order 2015), unreviewed Notice (Dec. 1, 2015).
Scientific Review Officer, Special Review On December 9, 2016, the ALJ issued
Branch, Division of Extramural Activities, AGENCY: U.S. International Trade her Final ID, finding a violation of
National Cancer Institute, NIH, 9609 Medical Commission. section 337 with respect to claims 1, 7,
Center Drive, Room 7W264, Bethesda, MD
ACTION: Notice. 9, 10, and 15 of the ’577 patent; and
20892–9750, 240–276–5864, jennifer.schiltz@
nih.gov. claims 1, 2, 4, 5, 7, 8, 10, 13, 18, 56, and
SUMMARY: Notice is hereby given that 64 of the ’668 patent. The ALJ found no
Name of Committee: National Cancer the U.S. International Trade
Institute Special Emphasis Panel; Biological violation of section 337 with respect to
Comparisons in Patient-Derived Models of
Commission has found a violation of claim 2 of the ’577 patent; claims 46 and
Cancer. section 337 of the Tariff Act of 1930, as 63 of the ’853 patent; claims 1, 3, and
Date: June 14, 2017. amended, in the above-captioned 4 of the ’492 patent; claims 1–4, and 10
Time: 1:00 p.m. to 4:30 p.m. investigation. The Commission has of the ’875 patent; and claims 2, 6, 13,
jstallworth on DSK7TPTVN1PROD with NOTICES

Agenda: To review and evaluate grant determined to issue a limited exclusion and 17 of the ’211 patent.
applications. order. The investigation is terminated. In particular, the Final ID finds that
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
FOR FURTHER INFORMATION CONTACT: Cisco has shown by a preponderance of
7W236, Rockville, MD 20850 (Telephone Megan M. Valentine, Office of the the evidence that the accused products
Conference Call). General Counsel, U.S. International infringe asserted claims 1, 7, 9, 10, and
Contact Person: Robert Coyne, Ph.D., Trade Commission, 500 E Street SW., 15 of the ’577 patent; and asserted
Scientific Review Officer, Special Review Washington, DC 20436, telephone (202) claims 1, 2, 4, 5, 7, 8, 10, 13, 18, 56, and

VerDate Sep<11>2014 15:21 May 09, 2017 Jkt 241001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\10MYN1.SGM 10MYN1

Document Created: 2017-05-10 00:01:09
Document Modified: 2017-05-10 00:01:09

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		82 FR 21826

82 FR 21826 - National Library of Medicine Amended; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 89 (May 10, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health